Join
Live feed
·
INSIDERFilingvia Quantisnow
Aptevo Therapeutics Inc. logo

EVP, COO Lamothe Jeffrey G. converted options into 314 shares, increasing direct ownership by 37% to 1,166 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APVO· Aptevo Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APVO (Aptevo Therapeutics Inc.) and more on Quantisnow.